Home/Boston Scientific/Michael F. Mahoney

MF

Michael F. Mahoney

Chairman and Chief Executive Officer

Boston Scientific

Therapeutic Areas

Cardiovascular Neuromodulation Endoscopy Oncology Urology Pelvic Health

Boston Scientific Pipeline

Drug	Indication	Phase
FARAPULSE PFA System	Atrial Fibrillation	FDA Approved
AGENT DCB	Coronary In-Stent Restenosis	FDA Approved
Ranger DCB	Peripheral Artery Disease	Pivotal Trial
ACURATE neo2	Aortic Stenosis (TAVI)	Pivotal Trial

Leadership Team at Boston Scientific

Daniel J. Brennan

Executive Vice President and Chief Financial Officer

Joseph M. Fitzgerald

Executive Vice President and President, MedSurg

Michael C. Kaufmann

Executive Vice President and President, Cardiovascular

Wendy Carruthers

Executive Vice President and President, Rhythm Management & Neuromodulation

Dr. Ian T. Meredith

Executive Vice President and Global Chief Medical Officer

View full Boston Scientific profile